Sunday, April 12, 2026 | 06:27 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 706 - Coronavirus Vaccine

US surpasses 350,000 coronavirus deaths: Johns Hopkins University

The United States surpassed 350,000 Covid-19 deaths on Sunday, according to data from Johns Hopkins University, as vaccinations against the virus have begun at a slow pace

US surpasses 350,000 coronavirus deaths: Johns Hopkins University
Updated On : 03 Jan 2021 | 4:01 PM IST

WHO hails India's emergency use authorisation approval to Covid vaccines

World Health Organisation (WHO) has welcomed India's decision giving emergency use authorisation to Covid-19 vaccines, informed Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia

WHO hails India's emergency use authorisation approval to Covid vaccines
Updated On : 03 Jan 2021 | 3:59 PM IST

Saudi Arabia lifts ban on international flights, land and sea entry

Saudi Arabia announced on Sunday the lifting of the ban on all international flights as well as land and sea entry, the Saudi Press Agency reported

Saudi Arabia lifts ban on international flights, land and sea entry
Updated On : 03 Jan 2021 | 3:51 PM IST

160,000 health workers to be first to get Covid vaccine in Punjab: Minister

Around 160,000 health workers in Punjab will receive a Covid-19 vaccine in the first phase, Health Minister Balbir Singh Sidhu said on Sunday

160,000 health workers to be first to get Covid vaccine in Punjab: Minister
Updated On : 03 Jan 2021 | 3:50 PM IST

Coronavirus LIVE: India's active caseload drops below 250,000 mark

Coronavirus live updates: At 1,938,854, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 918,544, Andhra Pradesh 882,612, Tamil Nadu 818,935, and Kerala 765,924

Coronavirus LIVE: India's active caseload drops below 250,000 mark
Updated On : 03 Jan 2021 | 3:04 PM IST

A decisive turning point: PM Modi on coronavirus vaccine approval

Prime Minister Modi lauded scientists of the country after DCGI gave approval to Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

A decisive turning point: PM Modi on coronavirus vaccine approval
Updated On : 03 Jan 2021 | 2:57 PM IST

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval

Bharat Biotech on Sunday said the approval for emergency use of its Covid-19 vaccine-- Covaxin-- is a giant leap for innovation and novel product development in India

Our goal now is to provide it globally: Bharat Biotech on Covaxin approval
Updated On : 03 Jan 2021 | 2:44 PM IST

Approval to Covaxin premature, could be dangerous, says Shashi Tharoor

Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to Covid-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial

Approval to Covaxin premature, could be dangerous, says Shashi Tharoor
Updated On : 03 Jan 2021 | 2:39 PM IST

World Coronavirus Dispatch: Why UK is delaying second dose of vaccines

Last Covid effects, Taiwan plans Covid free country, fresh wave in South Korea, and other pandemic-related news from across the globe

World Coronavirus Dispatch: Why UK is delaying second dose of vaccines
Updated On : 03 Jan 2021 | 2:24 PM IST

India's Covid-19 active caseload drops below 250,000: Health ministry

The Covid-19 active caseload in India has dropped below 250,000 with the recoveries exceeding new cases and low number of fatalities per day, the Health ministry said on Sunday

India's Covid-19 active caseload drops below 250,000: Health ministry
Updated On : 03 Jan 2021 | 2:23 PM IST

India will become coronavirus-free, says MoS Health Ashwini Kumar Choubey

With vaccines of Serum Institute and Bharat Biotech being granted permission for restricted use, Union Minister of State for Health Ashwini Choubey stated India will become corona-free

India will become coronavirus-free, says MoS Health Ashwini Kumar Choubey
Updated On : 03 Jan 2021 | 2:20 PM IST

Mayawati welcomes Covid-19 vaccine nod, urges govt to make it free for poor

Bahujan Samaj Party supremo Mayawati on Sunday congratulated the scientists associated with the coronavirus vaccine and urged the Centre to make it available for the poor free of cost

Mayawati welcomes Covid-19 vaccine nod, urges govt to make it free for poor
Updated On : 03 Jan 2021 | 2:00 PM IST

India Coronavirus Dispatch: India's 'R value' remains unchanged at 0.90

Steps to self-register for vaccination drive, findings from a study on impact to brain tissue, pictures from Delhi's Covid-19 vaccine dry run-news relevant to India's fight against Covid-19

India Coronavirus Dispatch: India's 'R value' remains unchanged at 0.90
Updated On : 03 Jan 2021 | 1:54 PM IST

Production to vaccination: Where are we in the Covid-19 vaccine race?

The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic, which has killed more than 1.8 million people worldwide

Production to vaccination: Where are we in the Covid-19 vaccine race?
Updated On : 03 Jan 2021 | 1:12 PM IST

Approval for vaccines accelerates India's journey to be Covid-free: Modi

Modi said it will make every Indian proud that both the vaccines are made in India

Approval for vaccines accelerates India's journey to be Covid-free: Modi
Updated On : 03 Jan 2021 | 12:12 PM IST

India approves two coronavirus vaccines for restrictive, emergency use

Drug Controller General of India (DCGI) V.G. Somani on Sunday approved Serum Institute of India's 'Covishield' vaccine and Bharat Biotech's 'Covaxin' for emergency use

India approves two coronavirus vaccines for restrictive, emergency use
Updated On : 03 Jan 2021 | 11:50 AM IST

'Covishield' vaccine ready to roll out in coming weeks: Adar Poonawalla

Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca COVID-19 vaccine 'Covishield' is ready to roll out in the coming weeks. Poonawalla's remarks came soon after after India's drugs regulator approved Covishield for restricted emergency use. "Happy new year, everyone! All the risks @SerumInstIndia took with stockpiling the vaccine, have finally paid off. COVISHIELD, India's first COVID-19 vaccine is approved, safe, effective and ready to roll-out in the coming weeks," Poonawalla tweeted. "Thank you Hon. Sri @narendramodi Ji, Hon. Sri @drharshvardhan Ji, @MoHFW_INDIA @ICMRDELHI @DBTIndia #DCGI_India @UniofOxford @AstraZeneca @gavi @GaviSeth @gatesfoundation and @BillGates for your support," he added.

'Covishield' vaccine ready to roll out in coming weeks: Adar Poonawalla
Updated On : 03 Jan 2021 | 11:50 AM IST

Macro data, vaccination, quarterly earnings to drive markets this week

On a weekly basis, the Sensex advanced 895.44 points or 1.90 per cent, while the Nifty climbed 269.25 points or 1.95 per cent

Macro data, vaccination, quarterly earnings to drive markets this week
Updated On : 03 Jan 2021 | 11:20 AM IST

Covid-19: 18,177 new cases take India's virus tally to 1,03,23,965

The total coronavirus cases mounted to 1,03,23,965 and the death toll climbed to 1,49,435 with the novel coronavirus virus claiming 217 lives in a span of 24 hours in the country

Covid-19: 18,177 new cases take India's virus tally to 1,03,23,965
Updated On : 03 Jan 2021 | 10:14 AM IST

Global Covid-19 cases top 84.5 million, US worst-hit: Johns Hopkins

India comes in second place in terms of cases at 10,305,788, while the country's death toll soared to 149,218

Global Covid-19 cases top 84.5 million, US worst-hit: Johns Hopkins
Updated On : 03 Jan 2021 | 9:14 AM IST